NITROGLYCERIN IN DEXTROSE 5% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nitroglycerin In Dextrose 5%, and when can generic versions of Nitroglycerin In Dextrose 5% launch?
Nitroglycerin In Dextrose 5% is a drug marketed by Baxter Hlthcare and Hospira and is included in five NDAs.
The generic ingredient in NITROGLYCERIN IN DEXTROSE 5% is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nitroglycerin In Dextrose 5%
A generic version of NITROGLYCERIN IN DEXTROSE 5% was approved as nitroglycerin by AM REGENT on May 24th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NITROGLYCERIN IN DEXTROSE 5%?
- What are the global sales for NITROGLYCERIN IN DEXTROSE 5%?
- What is Average Wholesale Price for NITROGLYCERIN IN DEXTROSE 5%?
Summary for NITROGLYCERIN IN DEXTROSE 5%
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Clinical Trials: | 188 |
DailyMed Link: | NITROGLYCERIN IN DEXTROSE 5% at DailyMed |
Recent Clinical Trials for NITROGLYCERIN IN DEXTROSE 5%
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Alexandria University | Phase 2/Phase 3 |
Huizhou Municipal Central Hospital | N/A |
Xuzhou Central Hospital | N/A |
Pharmacology for NITROGLYCERIN IN DEXTROSE 5%
Drug Class | Nitrate Vasodilator |
Physiological Effect | Vasodilation |